A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

News

QVQ joins the Biotech Investissement Group

Date of publication : 12/10/2018

Dear Customers and Partners

We are pleased to announce that QVQ, a company based in Utrecht (The Netherlands), is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (Biotech Investissement Group – www.mabexperts.com).

QVQ has strong expertise in the development and production of single domain antibodies derived from llamas, which are referred to as VHHs. VHHs have unique biochemical properties due to their small size and high stability which make them very useful for tumour targeting particularly in imaging technologies and companion diagnostics. QVQ offers multiple services related to development, reformatting and optimization of VHHs with respect to stability, production levels and humanization. Besides contract research and services, QVQ has developed a growing portfolio of proprietary detection/imaging VHHs directed against targets in disease related with oncology, age disease and infectious diseases.

By joining the Biotech Investissement group, QVQ will complement the high level of expertise already present within the group, to develop and market new high-quality diagnostic assays and imaging products.

Please do not hesitate to get in touch if you require information about the QVQ products and services.

Yours faithfully

 Philippe Dulieu, CEO

Contact:

Phone +33(0)3 81 53 88 37 – Mail : info@mabexperts.com

  • QVQ joins the Biotech Investissement Group
    Date of publication : 12/10/2018

    Dear Customers and Partners

    We are pleased to announce that QVQ, a company based in Utrecht (The Netherlands), is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (Biotech...

    Read more
  • Bioproduction vol.8 Proteins & Antibodies
    Date of publication : 05/09/2018


    Diaclone will be present at the B4B Connections congress in Toulouse (France) dedicated to “BIOPRODUCTION, PROTEINS & ANTIBODIES”, February 6 and 7th, 2019.

    We will be happy to...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more
  • Diaclone recrute!
    Diaclone is recruting !
    Date of publication : 01/06/2018

    As part of its development, Diaclone is recruiting a sales technician based in Besancon, France to promote and sell its products and services to pharmaceutical, academic and specialized laboratories...

    Read more